Pharmaceutical Injectables In Ukrainka

MOQ25 Kilograms/Kilograms

Medicine TypeVeterinary Raw Materials

Physical FormPowder

IngredientsAnimal Extract

Recommended ForHorse, Dogs, Cattle

Storage InstructionsRoom Temperature

MOQ10000 Piece/Pieces

Drug TypeInjection

Physical FormLiquid

Dosage GuidelinesDosage Guidelines

Quantity10000 Pieces

Storage Instructionsstorage lnstructions

MOQ1 Lac Piece/Pieces

Drug TypeInjection

IngredientsFligrastim Injection I.P.PFS 300mcg Recombinant Human Granulocyte Colony Stimulating Factor(rHu G-CSF) Injection

Physical FormLiquid

FunctionAnti-Cancer

Recommended ForChemotherapy

Dosage300 MCG

MOQ5000 Pack/Packs

Drug TypeInjection

Physical FormLiquid

FunctionOther

Suitable ForChildren, Teenagers, Women, Adults, Suitable For All, Aged Person

Quantity5000 Unit

Storage InstructionsNORMAL TEMP

MOQ10000 Box/Boxes

Drug TypeGeneral Medicines

Physical FormLiquid

DosageAs Prescribed By The Physician

Suitable ForAdults, Aged Person

Storage InstructionsStore In Cold/Dry Place

MOQ5 Box/Boxes

Drug TypeInjection

Physical FormLiquid

Dosage1mg

Dosage GuidelinesAs Per Suggestion

Suitable ForSuitable For All

Storage InstructionsDark & Dry Place

MOQ1 Kilograms/Kilograms

FOB Portindia

Payment TermsLetter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Cash Against Delivery (CAD), Telegraphic Transfer (T/T)

Delivery Time30 Days

MOQ500 Piece/Pieces

Supply Ability10000 Per Week

Delivery Time2-7 Days

MOQ10000 Unit/Units

Drug TypeInjection

Physical FormLiquid

DosageAs per suggestion

Storage InstructionsDry Place

MOQ1800 Piece/Pieces

Drug TypeInjection

Physical FormLiquid

IngredientsBortezomib.

Dosage2 mg/ Vial

Dosage GuidelinesAs guided by physician

Quantityper Box 1 vial Unit

Storage InstructionsKeep out of the reach and sight of children. Do not store above 30C. Keep the vial in the outer carton in order to protect from light. Do not use after the expiry date stated on the vial and the carton after EXP. The reconstituted solution should be used immediately after preparation. If the reconstituted solution is not used immediately, in-use storage times and conditions prior to use are the responsibility of the user. However, the reconstituted solution is stable for 8 hours at 25 AdegC in the original vial and/or a syringe prior to administration, with a maximum of 8 hours in the syringe.